学術情報 -AJRCCM(ブルージャーナル)-

本誌は、American Thoracic Society(米国胸部学会)の発行するAmerican Journal of Respiratory and Critical Care Medicineをもとに、シュプリンガー・ジャパン株式会社が公正中立の立場で論文選択、翻訳等を含む作業全般を担っている医療関係者向けの資材です。

弊社は、医療関係者に有益な情報を提供することを通じて医療に貢献することを目的に本資材の提供を行っており、本資材作成にかかる費用を負担しています。

本資材には本邦における未承認の医薬品、効能・効果及び用法・用量等の情報が含まれる場合がありますが、これを推奨するものではありません。

本資材を受領される際には、以下の内容をご確認いただきたく存じます。

  • 本資材に記載された薬剤の使用にあたっては、最新の添付文書をご参照ください。
  • 本資材は医療関係者からの求めに応じて提供するものであり、企業が積極的に提供するものではありません。

2019年10月 -PART 01-

アスピリン喘息におけるバイオマーカーに及ぼすアスピリンのユニークな治療効果
前向き試験

Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-exacerbated Respiratory Disease
A Prospective Trial
Am J Respir Crit Care Med 2019; 200(6): 704‒711

喘息転帰に対するハウスエンドトキシン曝露と環境大気汚染の相乗的な関連性

Synergistic Association of House Endotoxin Exposure and Ambient Air Pollution with Asthma Outcomes
Am J Respir Crit Care Med 2019; 200(6): 712‒720

慢性閉塞性肺疾患(COPD)の発症に関わる遺伝的リスクスコアとCTによる肺構造との関連性

A Genetic Risk Score Associated with Chronic Obstructive Pulmonary Disease Susceptibility and Lung Structure on Computed Tomography
Am J Respir Crit Care Med 2019; 200(6): 721‒731

2019年09月 -PART 02-

ディーゼル排気の粒子除去は交通関連大気汚染とアレルゲンの急性的な影響を修正しない
無作為化二重盲検クロスオーバー試験

Particle Depletion Does Not Remediate Acute Effects of Traffic-related Air Pollution and Allergen A Randomized, Double-Blind Crossover Study
Am J Respir Crit Care Med 2019; 200(5): 565‒574

重症慢性閉塞性肺疾患(COPD)における非侵襲的イメージングバイオマーカーによる末梢気道損傷の検出

Noninvasive Imaging Biomarker Identifies Small Airway Damage in Severe Chronic Obstructive Pulmonary Disease
Am J Respir Crit Care Med 2019; 200(5): 575‒581

出生時の二酸化窒素への曝露は成年期に至るまでCC16濃度と関連する

CC16 Levels into Adult Life Are Associated with Nitrogen Dioxide Exposure at Birth
Am J Respir Crit Care Med 2019; 200(5): 600-607

Selected articles from AJRCCM. Copyright 2018 by the American Thoracic Society. All rights reserved. The ideas and opinions expressed in the American Journal of Respiratory and Critical Care Medicine (AJRCCM) or other associated publications do not necessarily reflect those of the American Thoracic Society (ATS). The authors, editors or ATS are not responsible for errors or omissions of articles published in print or online from AJRCCM or other associated ATS publications. Although great care has been taken in compiling the content of this publication, neither ATS or their servants are responsible or liable in any way for the currency of the information, for any errors, omissions or inaccuracies, or for any consequences arising there from. Approved product information should be reviewed before prescribing. The mention of any product, service, or therapy in this publication should not be construed as an endorsement of the products mentioned. It is the responsibility of the treating physician or other health care provider, relying on independent experience and knowledge of the patient, to determine drug dosages and the best treatment for the patient. Readers are advised to check the appropriate medical literature and the product information currently provided by the manufacturer of each drug to be administered to verify the dosage, method, and duration of administration, or contraindications. Readers are also encouraged to contact the manufacturer with questions about the features or limitations of any products. ATS assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the material contained in this publication or to any errors or omissions. 

The translation is © 2018 American Thoracic Society. American Thoracic Society or Springer Healthcare takes no responsibility for the accuracy of the translation from the published English original and are not liable for any errors that may occur.